Direct (Toxic Nephropathy)
Immunological Drug-Associated Renal Disease. Drugs such as penicillins, sulfonamides, phenytoin, and allopurinol may be associated with the development of hypersensitivity vasculitis. This is a systemic disorder characterized by the deposition of immune complexes in the small blood vessels of the kidney and the skin. The renal histopathology is that of a proliferative glomerulonephritis. The renal prognosis of this disease is good, and the lesion usually resolves when the offending agent is discontinued.
By contrast to systemic immunological disease with glomerular involvement, primary glomerular injury is associated with drugs such as gold salts and penicillamine. The histological lesion is that of membranous glomerulonephritis. The clinical manifestations of proteinuria and hematuria as well as the histological abnormalities frequently resolve when the drugs are stopped.
The interstitium of the kidney may also be involved in an immunologically mediated renal inflammatory response associated with the ingestion of certain drugs. Agents such as the penicillin derivatives, particularly methicillin, are associated with the development of acute interstitial nephritis. Allopurinol, cimetidine, phenytoin, rifampin, and sulfonamides, as well as a variety of other drugs, have been associated with the development of acute interstitial nephritis. On histological examination of the kidney, there is an interstitial inflammatory response characterized by infiltration of eosinophils. The patient may have fever, rash, and eosinophilia in addition to renal dysfunction. Many patients with this drugrelated syndrome, however, manifest only the renal functional impairment. The prognosis is generally good, and renal function improves when there is no longer an exposure to the offending agent. Occasionally, a short course of corticosteroids is indicated to hasten the resolution of the disease.
Nonsteroidal anti-inflammatory drugs have also been associated with the development of acute interstitial nephritis. The inflammatory cell seen on histological examination of the kidney is the lymphocyte. Nonsteroidal anti-inflammatory drug-induced interstitial nephritis may also be accompanied by the development of the nephrotic syndrome. Discontinuance of the drug, with or without the administration of corticosteroids, usually results in resolution of the injury.
Direct Tubular Toxicity. Certain classes of drugs appear to have the capability of causing direct damage to the renal tubular cells. The clinical presentation is that of the acute renal failure syndrome. The aminoglycoside antibiotics and the cancer chemotherapeutic agent, cis-platinum, are common causes ci the acute renal failure syndrome. The clinical characteristics of this syndrome are discussed in Chapter 32. Although the mechanism of injury differs with different drugs, there is, ultimately, a disturbance in the function of the renal tubular cells.
In addition to the morphological and functional disturbances associated with the development of acute renal insufficiency, a number of drugs are associated with impairments of specific tubular functions. In these conditions, the glomerular filtration rate may or may not be normal. Derangements in proximal tubular function occur with exposure to heavy metals and outdated tetracycline. The manifestations may include renal tubular acidosis, phosphaturia, and glycosuria. Impairment in the ability to concentrate the urine may be seen in patients taking lithium carbonate, demethyl-chlortetracycline, or amphotericin B. Diabetes insipidus is the clinical expression of this defect. Drugs such as vincristine, cyclophosphamide, and chlorpropamide may be associated with impairment in the ability to excrete a water load and to dilute the urine. Hyperkalemia and distal renal tubular acidosis may be seen in patients receiving amphotericin B, beta-adrenergic blocking agents, and nonsteroidal anti-inflammatory drugs.
- Systemic Lupus Erythematosus (SLE)
- Multiple Myeloma
- MULTISYSTEM DISEASE WITH RENAL INVOLVEMENT
- Urinary Tract Infection
- Urinary Tract Obstruction
- Indirect
- Urolithiasis
- Alterations in Drug Doses in Patients with Renal Failure
- DRUG-ASSOCIATED RENAL INJURY
- RENAL PHARMACOLOGY
- RENAL METABOLISM Of DRUGS
- Metabolism of Drugs in Patients with Renal Insufficiency
- Direct (Toxic Nephropathy)
- Amyloidosis
- Sickle Cell Anemia (SS)
- Hepatic Diseases
- Diabetes Mellitus (DM)
- Disorders of Pregnancy